Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 9 member C (FAM9C) is a nuclear protein encoded by a gene on the X chromosome, sharing homology with the synaptonemal complex component SYCP3, and containing multiple nuclear localization signals[1][3][6]. It is expressed predominantly in the testis, where it may play a role in meiotic chromatin organization and recombination during spermatogenesis[1][3]. Evidence also implicates FAM9C as a cancer-testis antigen in hepatocellular carcinoma (HCC), where it is frequently upregulated and associated with enhanced cell proliferation, tumorigenicity, and inhibition of apoptosis via activation of the PI3K/Akt pathway[1]. There are no known drugs directly targeting FAM9C, nor is it well established as a therapeutic target. It may serve as a biomarker for certain cancers but currently lacks validated safety data or drug interaction evidence[1][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 9 member C (FAM9C).